Neill, J
Consent for publication All authors consent for the publication of this study
Oral semaglutide may potentially alter the pharmacokinetics of concomitantly administered drugs (victim drugs) via the effect on gastric emptying (as has been shown for other GLP-1RAs [21]) or via the effects of the absorption enhancer SNAC, although recent drugdrug interaction (DDI) studies found that oral semaglutide had no clinically meaningful effect on the exposure of four victim drugs (lisinopril, warfarin, digoxin and metformin) commonly used in patients with T2D [23]
Oral tirzepatide comes only as dissolving tablets, since Henry offers no injectable tirzepatide as of July 2026, sold as a three-month supply at $1,047, or $891 paid in full, with no published month-to-month rate
Jha U, Asad M, Asdaq SMB, Das AK, Prasad VS
Most GLP-1 drugs were initially approved by the FDA to treat Type 2 diabetes